Topics

Cross Over Study to Prove Bioequivalence Between Two Brands of Cefalexin Suspension

2014-08-27 03:14:32 | BioPortfolio

Summary

A single dose, two treatments (two cephalexin suspension brands), two sequences, cross-over design was used with a washout of 7 days between the two study periods. Treatment groups balanced with the same number of healthy volunteers who were randomly (in two strata: male and female) assigned to the study drug administration sequences

Study Design

Allocation: Randomized, Endpoint Classification: Bio-equivalence Study, Intervention Model: Crossover Assignment, Masking: Open Label, Primary Purpose: Treatment

Conditions

Anti-Infective Agents

Intervention

Cephalexin suspension (Optocef, BAYO5448 ), Cephalexin suspension (Keflex)

Location

Morelia
Michoacán
Mexico
58256

Status

Completed

Source

Bayer

Results (where available)

View Results

Links

Published on BioPortfolio: 2014-08-27T03:14:32-0400

Clinical Trials [847 Associated Clinical Trials listed on BioPortfolio]

Cross-over Study to Prove Bioequivalence Between Two Brands of Cefalexin Suspension

A single dose, two treatments (two cephalexin suspension brands), two sequences, cross-over design was used with a washout of 7 days between the two study periods. Treatment groups balance...

Cross-over Study to Prove Bioequivalence Between Two Brands of Cefalexin Capsules

A single dose, two treatments (two cephalexin capsules brands), two sequences, cross-over design was used with a washout of 7 days between the two study periods. Treatment groups balanced...

A Study of Cephalexin Liquid in Healthy Participants

The purpose of this study is to compare two different preparations of an antibiotic called cephalexin to determine if they are essentially the same. The study has two periods. Participants...

Antibiotics for Prevention of SSI in Obese Women Undergoing CS

Effect of cephalexin plus metronidazole on SSI better than cephalexin alone in obese women undergoing CS

Ciprofloxacin Compared With Cephalexin in Treating Patients With Bladder Cancer

RATIONALE: Chemoprevention therapy is the use of certain drugs to try to prevent the development or recurrence of cancer. It is not yet known whether ciprofloxacin is more effective than c...

PubMed Articles [6240 Associated PubMed Articles listed on BioPortfolio]

Preparation, physicochemical properties, in vitro evaluation and release behavior of cephalexin-loaded niosomes.

In this study, optimized cephalexin-loaded niosomal formulations based on span60 and tween60 were prepared as a promising drug carrier system. The niosomal formulations were characterized using a seri...

Photocatalytic degradation of cephalexin by ZnO nanowires under simulated sunlight: Kinetics, influencing factors, and mechanisms.

Increasing concentrations of anthropogenic antibiotics and their metabolites in aqueous environments has caused growing concerns over the proliferation of antibiotic resistance and potential adverse i...

Determination of cephalexin residual level using ultra-high-performance liquid chromatography-tandem mass spectrometry: Residue depletion study in swine.

An ultra-high-performance liquid chromatography-tandem mass spectrometry method was developed to analyze cephalexin in swine tissues, urine, and feces. Samples were extracted with 1% sulfuric acid, fo...

Teaching learners to raise the roof: a vaginal surgery simulator for apical suspension.

The objective was to discuss the importance of apical suspension following vaginal hysterectomy and demonstrate a surgical model to aide in educating learners on a variety of apical suspension procedu...

Cometabolic biodegradation of cephalexin by enriched nitrifying sludge: Process characteristics, gene expression and product biotoxicity.

The nitrifying systems have been reported to be able to biodegrade micropollutants, yet it is still unclear about the cometabolism of ammonia-oxidizing bacteria (AOB) towards micropollutants, in parti...

Medical and Biotech [MESH] Definitions

Semisynthetic, broad-spectrum antibiotic derivative of CEPHALEXIN.

Long-acting, broad-spectrum, water-soluble, CEPHALEXIN derivative.

A semisynthetic cephalosporin antibiotic with antimicrobial activity similar to that of CEPHALORIDINE or CEPHALOTHIN, but somewhat less potent. It is effective against both gram-positive and gram-negative organisms.

A readily reversible suspension of sensorimotor interaction with the environment, usually associated with recumbency and immobility.

Visible gaseous suspension of carbon and other particulate matter emitted from burning substances.

More From BioPortfolio on "Cross Over Study to Prove Bioequivalence Between Two Brands of Cefalexin Suspension"

Quick Search

Relevant Topics

Nutrition
Within medicine, nutrition (the study of food and the effect of its components on the body) has many different roles. Appropriate nutrition can help prevent certain diseases, or treat others. In critically ill patients, artificial feeding by tubes need t...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...


Searches Linking to this Trial